Regardless, the reduction of dural ECM remodeler (Mmp9) was observed in the high dose of CLL-treated mice, where dural LYVE-1+ macrophages were selectively depleted, which synchronized the disrupted CSF drainage after CLL treatment. The gene discussed is MMP9; the disease is B-cell chronic lymphocytic leukemia.